X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (12322) 12322
Book Review (4044) 4044
Publication (1247) 1247
Book Chapter (106) 106
Conference Proceeding (25) 25
Book / eBook (14) 14
Dissertation (11) 11
Web Resource (4) 4
Magazine Article (3) 3
Presentation (3) 3
Data Set (2) 2
Journal / eJournal (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (9558) 9558
humans (8741) 8741
oncology (6856) 6856
metastatic colorectal-cancer (5199) 5199
cancer (3995) 3995
female (3993) 3993
male (3450) 3450
chemotherapy (3301) 3301
middle aged (3025) 3025
aged (2893) 2893
adult (2301) 2301
metastasis (2211) 2211
colorectal cancer (2136) 2136
animals (1932) 1932
care and treatment (1840) 1840
treatment outcome (1644) 1644
bevacizumab (1574) 1574
tumors (1541) 1541
antineoplastic combined chemotherapy protocols - therapeutic use (1538) 1538
metastatic colorectal cancer (1524) 1524
metastatic breast-cancer (1480) 1480
pharmacology & pharmacy (1474) 1474
cell lung-cancer (1447) 1447
research (1444) 1444
antineoplastic agents - therapeutic use (1382) 1382
neoplasms - drug therapy (1379) 1379
prognosis (1363) 1363
fluorouracil (1344) 1344
survival (1294) 1294
colorectal neoplasms - drug therapy (1215) 1215
medicine & public health (1194) 1194
aged, 80 and over (1149) 1149
cetuximab (1141) 1141
colorectal neoplasms - pathology (1122) 1122
breast-cancer (1115) 1115
therapy (1107) 1107
analysis (1090) 1090
metastatic melanoma (1086) 1086
health aspects (1062) 1062
oxaliplatin (1042) 1042
1st-line treatment (1041) 1041
surgery (1031) 1031
leucovorin (981) 981
colorectal-cancer (971) 971
neoplasm metastasis (969) 969
irinotecan (940) 940
mutation (913) 913
immunotherapy (888) 888
disease-free survival (858) 858
endothelial growth-factor (825) 825
cancer therapies (823) 823
drug therapy (823) 823
fluorouracil - administration & dosage (821) 821
phase-ii trial (806) 806
clinical trials (799) 799
camptothecin - analogs & derivatives (789) 789
carcinoma (779) 779
patients (773) 773
angiogenesis (766) 766
phase-iii trial (763) 763
antibodies, monoclonal - therapeutic use (753) 753
cell line, tumor (753) 753
neoplasm staging (753) 753
breast cancer (745) 745
growth-factor receptor (745) 745
mice (735) 735
capecitabine (720) 720
antineoplastic combined chemotherapy protocols - adverse effects (711) 711
trial (695) 695
expression (684) 684
article (680) 680
hematology, oncology and palliative medicine (675) 675
5-fluorouracil (672) 672
phase-ii (663) 663
retrospective studies (660) 660
lung-cancer (659) 659
melanoma (652) 652
cell biology (650) 650
genetic aspects (650) 650
metastases (645) 645
review (636) 636
cancer research (635) 635
clinical trials as topic (635) 635
medicine, research & experimental (630) 630
antineoplastic agents (622) 622
antineoplastic agents - pharmacology (620) 620
antibodies, monoclonal, humanized (609) 609
neoplasms - therapy (607) 607
development and progression (593) 593
survival analysis (592) 592
antimitotic agents (587) 587
antineoplastic agents - adverse effects (582) 582
biomarkers (566) 566
vascular endothelial growth factor (561) 561
survival rate (560) 560
neoplasms - pathology (552) 552
randomized-trial (549) 549
deoxycytidine - analogs & derivatives (538) 538
immunology (535) 535
angiogenesis inhibitors - therapeutic use (526) 526
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (11973) 11973
French (170) 170
German (115) 115
Japanese (59) 59
Spanish (28) 28
Russian (25) 25
Italian (11) 11
Polish (8) 8
Chinese (5) 5
Czech (5) 5
Korean (5) 5
Turkish (4) 4
Hungarian (3) 3
Icelandic (1) 1
Latvian (1) 1
Lithuanian (1) 1
Portuguese (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
European Journal of Cancer, ISSN 0959-8049, 2016, Volume 70, pp. 87 - 98
Journal Article
Annals of Oncology, ISSN 0923-7534, 2014, Volume 25, Issue 7, pp. 1346 - 1355
Journal Article
Cancer Discovery, ISSN 2159-8274, 04/2015, Volume 5, Issue 4, pp. 358 - 367
Journal Article
Journal Article
Journal Article
International Journal of Oncology, ISSN 1019-6439, 09/2017, Volume 51, Issue 3, pp. 975 - 986
Colorectal cancer (CRC) is one of the most common solid organ cancers prevalent worldwide causing, in spite of advancing therapeutic methodology, high rate of... 
FasR | colorectal cancer | cancer stem cells | FasL | Cancer stem cells | Colorectal cancer | APOPTOSIS | STEM-CELLS | CD95 | ACTIVATION | DEATH | COLON-CANCER | LIVER METASTASES | METASTATIC SPREAD | ONCOLOGY | LIGAND | EXPRESSION | Development and progression | Health aspects | Stem cells | Apoptosis | Medical prognosis | Defense mechanisms | Metastasis | Gene expression | Kinases
Journal Article
Expert Opinion on Biological Therapy, ISSN 1471-2598, 05/2019, Volume 19, Issue 5, pp. 411 - 422
Introduction: The combination of oxaliplatin, irinotecan, fluorouracil (5-FU), and leucovorin (FOLFOXIRI) results in improved outcomes compared with standard... 
cetuximab | metastatic colorectal cancer | panitumumab | FOLFOXIRI | Bevacizumab | MEDICINE, RESEARCH & EXPERIMENTAL | 1ST-LINE TREATMENT | INFUSIONAL FLUOROURACIL | RANDOMIZED-TRIAL | WILD-TYPE KRAS | OPEN-LABEL | PHASE-III TRIAL | LIVER METASTASES | TRIBE TRIAL | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | INITIAL THERAPY | COMBINATION CHEMOTHERAPY
Journal Article
Journal Article
Annals of Oncology, ISSN 0923-7534, 11/2009, Volume 20, Issue 11, pp. 1842 - 1847
Background: Bevacizumab significantly improves survival when added to chemotherapy for metastatic colorectal cancer (mCRC). The Bevacizumab Expanded Access... 
Expanded access study | Chemotherapy | First line | mCRC | Metastatic colorectal cancer | Bevacizumab | expanded access study | LEUCOVORIN | PHASE-II | first line | OXALIPLATIN | FLUOROURACIL | COMBINATION | chemotherapy | TRIAL | THERAPY | ONCOLOGY | bevacizumab | metastatic colorectal cancer | Leucovorin - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Young Adult | Antibodies, Monoclonal, Humanized | Organoplatinum Compounds - administration & dosage | Fluorouracil - administration & dosage | Leucovorin - adverse effects | Fluorouracil - adverse effects | Colorectal Neoplasms - drug therapy | Aged, 80 and over | Adult | Camptothecin - administration & dosage | Deoxycytidine - adverse effects | Female | Camptothecin - analogs & derivatives | Colorectal Neoplasms - mortality | Camptothecin - adverse effects | Fluorouracil - analogs & derivatives | Deoxycytidine - administration & dosage | Kaplan-Meier Estimate | Disease-Free Survival | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Deoxycytidine - analogs & derivatives | Organoplatinum Compounds - adverse effects | Index Medicus
Journal Article
JOURNAL OF NUCLEAR MEDICINE, ISSN 0161-5505, 08/2011, Volume 52, Issue 8, pp. 1173 - 1180
Humanized A33 (huA33) is a promising monoclonal antibody that recognizes A33 antigen, which is present in more than 95% of colorectal cancers and in normal... 
positron | A33 | HEPATOCELLULAR-CARCINOMA HCC | antibody | A33 ANTIGEN | I/II | RADIOIMMUNOTHERAPY | arterial | METASTATIC COLON-CANCER | RADIOLABELED MONOCLONAL-ANTIBODIES | THERAPY | ARTERIAL INFUSION | PHARMACOKINETICS | PHASE-I TRIAL | I-124 | colon | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Journal Article
Current Oncology Reports, ISSN 1523-3790, 6/2011, Volume 13, Issue 3, pp. 168 - 176
In the United States and Europe, colorectal cancer (CRC) is the third most common malignancy and the second leading cause of cancer-related death for men and... 
Neoadjuvant chemotherapy